Hims and Hers under scrutiny after weight loss ad during Super Bowl

Takeaways

The main points, in the order they come up. Tap a time to play from there.

1. 0:00 The report says the Hims and Hers Super Bowl ad criticizes the U.S. health care system and promotes the company's weight loss drug as a cheaper alternative to Ozempic and Wegovy.
2. 0:10 According to the report, the company's drug is compounded, which means it mixes multiple drugs and is not required to go through the FDA's full approval process.
3. 0:31 The report says the maker of Ozempic and Wegovy responded with a full page ad asking if people know what they are injecting.
4. 0:40 Two senators faulted the ad for lacking side effect, risk and safety information, according to the report.
5. 1:02 The report says Hims and Hers states it complies with existing law and takes safety, quality and transparency steps for every customer.
6. 1:32 According to the report, compounded versions have grown in popularity amid shortages of FDA approved options.

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Who is speaking

Patient

Read next

Our guides closest to what this video covers, with prices checked weekly.

• Is Hims legit? What its GLP-1 program costs, what reviews say, and its FDA record

  Yes. Hims & Hers is a real, licensed telehealth company, and as of October 2026 its weight-loss program sells FDA-approved brand-name GLP-1s: the Wegovy pill starts at $149 a month for the medication, plus a membership of $39 for the first month and $149 a month after, so about $298 a month from month two. It scores 2.9 on Trustpilot across 9,517 reviews, and FDA sent it a warning letter in September 2025 over compounded semaglutide marketing claims.

• Semaglutide for weight loss: which version, and what each costs

  Semaglutide is the molecule. For weight loss the FDA-approved version is Wegovy, sold as a weekly pen and a daily tablet. Ozempic is the same molecule approved for type 2 diabetes, so using it for weight is off-label. Compounded semaglutide is the same molecule from a compounding pharmacy, is not FDA-approved, and is what most cash buyers actually take because it costs a fraction of the brand. All three produce the same side effects. What differs is the approval, the oversight and the price.

• Ozempic side effects, and the ones that actually make people stop

  The common Ozempic side effects are gastrointestinal: nausea, vomiting, diarrhoea and constipation. They cluster in the first weeks and after each dose increase, which is why the drug is titrated slowly rather than started at the dose that does the work. Ozempic also carries a boxed warning for thyroid C-cell tumour risk, and the label for Wegovy, the same molecule, advises against combining it with another GLP-1. The practical thing nobody tells you: most people who quit do it during titration, and what decides whether that costs them money is the seller's pause and refund terms, not the sticker price.

Find more like it